Empower Your Fight Against Kidney Cancer
Kidney cancer frequently operates entirely blind to standard chemotherapy. Discover how preserving your renal tissue provides the essential key to mapping its highly unique vascular and immune environment.
Talk to a Care SpecialistWhat is Kidney Cancer?
Kidney cancer, most commonly Renal Cell Carcinoma (RCC), develops in the lining of the microscopic tubes in the kidney. RCC is uniquely highly vascular, meaning it aggressively grows its own blood vessel networks to sustain itself.
Because it is infamously resistant to conventional chemotherapy regimens, medical intervention heavily relies on cutting off its blood supply or unmasking it to the immune system.
What Does Kidney Cancer Do?
Tumors compromise blood filtration and frequently manipulate the body’s red cell production.
- Vascular Invasion: Renal tumors are notorious for growing directly into the major renal vein and sometimes up into the heart.
- Paraneoplastic Syndromes: The tumor secretes hormones that cause erratic blood pressure, dangerous calcium spikes, and extreme red blood cell counts.
- Silent Progression: Expanding in the deep abdominal space, it regularly achieves massive sizes before causing noticeable symptoms.
Current Treatment Options
Partial or Radical Nephrectomy
Surgical excision of the tumor alone (sparing the kidney) or the entire affected kidney and surrounding fat/lymph nodes.
Anti-Angiogenesis Drugs
Targeted oral therapies designed to blockade the signals the tumor uses to generate new, life-sustaining blood vessels.
Immune Checkpoint Inhibitors
Systemic infusions that disable the biological "brakes" on the immune system, empowering T-cells to identify and hunt the RCC.
Why Bank Your Living Kidney Tissue?
Renal cell carcinoma is wildly unpredictable in its response to immunotherapies. By biobanking your solid renal mass post-nephrectomy, you retain the ability to functionally test massive combinations of immune agents and targeted TKIs in a lab setting, preventing trial-and-error medicine.
Combination Efficacy Testing
Directly observe which combinations of TKI inhibitors and immunotherapies synergize best against your specific cells.
Microenvironment Reconstruction
3D modeling allows researchers to assess how your tumor builds its blood vessels and how to break them.
Targeted Biomarker Identification
Keep tissue biology pristine to quickly qualify for rapidly advancing molecular targeted trials in RCC.
Long-Term Preservation
Kidney cancer is notorious for late recurrences. Archived living tissue guarantees you possess your tumor's baseline data decades from now if needed.